Patient Guide: A Study of Nivolumab, Nivolumab Plus Ipilimumab, or Investigator's Choice Chemotherapy for the Treatment of Participants With Deficient Mismatch Repair (dMMR)/Microsatellite Instability High (MSI-H) Metastatic Colorectal Cancer (mCRC)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 157 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT04008030
Status: ACTIVE_NOT_RECRUITING
Condition: Metastatic Colorectal Cancer
Phase: PHASE3

Find a Study Location Near You

This study is available at 157 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Los Angeles, California
  • Sacramento, California
  • Denver, Colorado
  • • And 154 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily